Skip to content

Opening book details…

About this Medicine article

Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT by Boers-Sonderen, Marye J.; de Geus-Oei, Lioe-Fee; Desar, Ingrid M. E.; van der Graaf, Winette T. A.; Oyen, Wim J. G.; Ottevanger, Petronella B.; van Herpen, Carla M. L. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Boers-Sonderen, Marye J.; de Geus-Oei, Lioe-Fee; Desar, Ingrid M. E.; van der Graaf, Winette T. A.; Oyen, Wim J. G.; Ottevanger, Petronella B.; van Herpen, Carla M. L.
Publisher
Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC (ISSN 1776-2596)
Published
2014
Field
Medicine (Health Sciences)

More by Boers-Sonderen, Marye J.; de Geus-Oei, Lioe-Fee; Desar, Ingrid M. E.; van der Graaf, Winette T. A.; Oyen, Wim J. G.; Ottevanger, Petronella B.; van Herpen, Carla M. L.

Browse all works by Boers-Sonderen, Marye J.; de Geus-Oei, Lioe-Fee; Desar, Ingrid M. E.; van der Graaf, Winette T. A.; Oyen, Wim J. G.; Ottevanger, Petronella B.; van Herpen, Carla M. L.